Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xing-ran Jiang

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae|September 13, 2011
[Research advances in induced pluripotent stem cells]Xing-ran Jiang, Shi-xin Lu
Cancer Letters|July 22, 2014
RFT2 is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenesis by sustaining cell proliferation and protecting against cell deathXing-Ran Jiang, Xi-Ying Yu, Jin-Hu Fan, et al.
Cancer Science|January 4, 2014
Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapyXiao-Bing Wang, Xing-Ran Jiang, Xi-Ying Yu, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae|September 13, 2011
[Research advances in induced pluripotent stem cells]Xing-ran Jiang, Shi-xin Lu
Cancer Letters|July 22, 2014
RFT2 is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenesis by sustaining cell proliferation and protecting against cell deathXing-Ran Jiang, Xi-Ying Yu, Jin-Hu Fan, et al.
Cancer Science|January 4, 2014
Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapyXiao-Bing Wang, Xing-Ran Jiang, Xi-Ying Yu, et al.
Pageof 1